The list of shorts for Monday was rather relatively large, 9 stocks on the screening. Two semi related, CREE and SLAB, and the rest biotech/pharmaceutical, ALXN, HGSI, ITMN, MEDI, NPSP, OSIP, and VRTX.
The bio/pharm stocks have had the most run up the recent rally, with the weakest fundamentals supporting that move. I still believe that those groups are going to be one of the strongest the rest of this year, but if we are going to see continued sliding in the market these have some room below them.
Sam